Browsing Tag
CMND-100
2 posts
How Johns Hopkins IRB approval strengthens Clearmind Medicine’s clinical credibility in addiction medicine
Clearmind Medicine’s Johns Hopkins-backed CMND-100 trial expansion could reshape addiction therapeutics. Discover what industry observers are watching next.
Clearmind Medicine receives IRB approval in Israel for Phase 1/2a trial targeting alcohol use disorder
Clearmind Medicine wins IRB nod in Israel for its psychedelic-based AUD trial. Find out how this pivotal study could reshape addiction treatment.